Search Results - "Veeravalli, Sarath Chandra Mouli"
-
1
INCIDENCE OF PLEUROPULMONARY COMPLICATIONS IN 100 CONSECUTIVE PATIENTS WITH RHEUMATOID ARTHRITIS IN A TERTIARY HEALTH CARE CENTER
Published in Chest (01-10-2019)Get full text
Journal Article -
2
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Published in Annals of the rheumatic diseases (01-01-2020)“…To compare efficacy and safety of ixekizumab (IXE) to adalimumab (ADA) in biological disease-modifying antirheumatic drug-naïve patients with both active…”
Get more information
Journal Article -
3
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-06-2019)“…Objective Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA). The phase III, 24‐month, placebo‐controlled Oral Rheumatoid…”
Get full text
Journal Article -
4
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials
Published in JAMA : the journal of the American Medical Association (10-05-2016)“…IMPORTANCE: Digital ulcers in patients with systemic sclerosis are associated with pain and poor quality of life. Endothelin-1 promotes vasculopathy in…”
Get full text
Journal Article -
5
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
Published in Pediatric rheumatology online journal (30-07-2016)“…Fibromyalgia (FM) is a common pain condition characterized by widespread musculoskeletal pain and tenderness. Pregabalin is an approved treatment for adults in…”
Get full text
Journal Article -
6
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study
Published in International journal of rheumatic diseases (01-11-2016)“…Aim To conduct a subgroup analysis of GO‐MORE trial Part 1, comparing efficacy and safety of add‐on subcutaneous golimumab therapy in rheumatoid arthritis (RA)…”
Get full text
Journal Article